Complete Filing Data
GAXOS.AI INC. reported Net Income Loss of -$3.90 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean GAXOS.AI INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | -$3.9M | -$3.4M | -$3.9M | -$1.4M |
| Research And Development Expense | $993.7K | $996.5K | $915.8K | $824.5K |
| Operating Income Loss | -$4.9M | -$3.7M | -$4.0M | -$1.4M |
| Operating Expenses | $6.8M | $3.7M | $4.0M | $1.4M |
| General And Administrative Expense | $5.9M | $2.7M | $3.0M | $599.6K |
| Comprehensive Income Net Of Tax | -$4.3M | -$3.5M | -$3.9M | -$1.4M |
| Other Comprehensive Income Loss Net Of Tax | -$84.1K | $95.8K | ||
| Other Nonoperating Income Expense | $67.2K | $2.9K | ||
| Revenues | $1.9M | $4.0K | $256.00 | |
| Nonoperating Income Expense | $634.3K | $279.3K | $67.2K | |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $15.3K | -$84.1K | ||
| Goodwill Impairment Loss | ||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | $15.3K | -$84.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$1.0M | -$749.4K | -$1.2M | -$864.4K | -$809.2K | -$912.1K | -$857.1K | -$754.0K | -$1.5M | -$326.2K | -$464.1K | -$307.8K | -$12.3K |
| Research And Development Expense | $274.0K | $243.0K | $221.0K | $252.7K | $249.3K | $182.3K | $258.4K | $267.6K | $104.6K | $220.9K | $237.4K | $150.5K | $6.8K |
| Operating Income Loss | -$1.3M | -$982.7K | -$1.4M | -$905.9K | -$854.5K | -$1.0M | -$873.6K | -$768.6K | -$1.5M | -$326.6K | -$464.6K | -$308.2K | -$12.3K |
| Operating Expenses | $1.8M | $1.2M | $1.4M | $908.6K | $854.5K | $1.0M | $873.6K | $768.6K | $1.5M | $326.6K | $464.6K | $308.2K | $12.3K |
| General And Administrative Expense | $1.5M | $910.6K | $1.2M | $655.9K | $605.2K | $861.5K | $615.2K | $448.6K | $1.4M | $105.7K | $227.2K | $157.7K | $5.4K |
| Comprehensive Income Net Of Tax | -$1.1M | -$738.8K | -$1.3M | -$854.5K | -$802.2K | -$1.0M | -$815.2K | -$734.4K | -$1.5M | -$326.2K | -$464.1K | -$307.8K | |
| Other Comprehensive Income Loss Net Of Tax | $9.9K | $7.0K | -$99.4K | $41.8K | $19.6K | $18.2K | |||||||
| Other Nonoperating Income Expense | $131.7K | $16.6K | $14.6K | $6.3K | $354.00 | $517.00 | $371.00 | ||||||
| Revenues | $498.3K | $171.0K | $23.7K | $2.7K | $19.00 | ||||||||
| Nonoperating Income Expense | $173.9K | $158.1K | $159.6K | $41.5K | $45.3K | $131.7K | $16.6K | $14.6K | |||||
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | $47.1K | $85.7K | -$69.0K | $9.9K | $7.0K | -$99.4K | |||||||
| Goodwill Impairment Loss | $52.4K | ||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments Net Of Tax | $47.1K | $85.7K | $9.9K | $7.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity * | $13.1M | $16.6M | $3.4M | $685.7K | $2.1M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $840.8K | $14.4M | $1.0M | $679.8K | $2.1M |
| Unrealized Gain Loss On Investments | $21.9K | -$84.1K | $95.8K | ||
| Retained Earnings Accumulated Deficit | -$12.7M | -$8.8M | -$5.4M | -$1.4M | -$12.3K |
| Liabilities Current | $680.6K | $401.5K | $270.0K | $255.7K | $8.7K |
| Liabilities And Stockholders Equity | $13.4M | $17.0M | $3.7M | $941.4K | $2.1M |
| Liabilities | $680.6K | $401.5K | $270.0K | $255.7K | $8.7K |
| Common Stock Value | $712.00 | $692.00 | $99.00 | $87.00 | $1.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$13.6M | $13.4M | $344.9K | -$1.4M | |
| Assets Current | $12.6M | $16.8M | $3.6M | $882.8K | $2.1M |
| Assets | $13.4M | $17.0M | $3.7M | $941.4K | $2.1M |
| Accrued Liabilities Current | $280.4K | $61.6K | $54.2K | $10.7K | $2.5K |
| Accounts Payable Current | $270.1K | $338.8K | $215.9K | $245.0K | $6.3K |
| Prepaid Expense And Other Assets Current | $157.6K | $63.6K | $25.1K | $400.00 | |
| Assets Noncurrent | $821.7K | $195.4K | $53.4K | $58.6K | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | $27.0K | $11.7K | $95.8K | ||
| Property Plant And Equipment Net | $103.4K | $70.4K | $52.6K | ||
| Cash And Cash Equivalents At Carrying Value | $679.8K | $2.1M | |||
| Other Short Term Investments | $11.3M | $2.2M | $2.6M | ||
| Equity Securities Fv Ni | $180.0K | $200.0K | |||
| Intangible Assets Net Excluding Goodwill | $718.3K | $125.0K | $58.6K | ||
| Unrealizedloss Income On Shortterm Investments | -$84.1K | $95.8K | |||
| Reclassification Of Deferred Offering Costs To Equity | $202.6K | ||||
| Contract With Customer Liability Current | $130.1K | $1.1K | |||
| Accounts Receivable Net Current | $76.2K | $8.00 | |||
| Cash | $679.8K | $2.1M | |||
| Minority Interest | -$387.8K | -$6.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $14.1M | $15.0M | $15.6M | $6.7M | $4.7M | $5.5M | $4.2M | $5.1M | $5.8M | $685.7K | $1.0M | $1.3M | $1.8M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $914.2K | $1.7M | $2.6M | $5.2M | $2.4M | $3.3M | $765.0K | $1.7M | $2.2M | $978.5K | $1.4M | $1.8M | ||
| Unrealized Gain Loss On Investments | $7.4K | $8.6K | $9.9K | $7.0K | -$99.4K | $41.8K | $19.6K | $18.2K | ||||||
| Retained Earnings Accumulated Deficit | -$11.7M | -$10.7M | -$10.0M | -$8.0M | -$7.1M | -$6.3M | -$4.6M | -$3.7M | -$3.0M | |||||
| Liabilities Current | $451.9K | $505.5K | $500.7K | $404.9K | $392.1K | $513.8K | $201.5K | $277.0K | $149.3K | |||||
| Liabilities And Stockholders Equity | $14.3M | $15.4M | $16.1M | $7.1M | $5.1M | $6.0M | $4.4M | $5.3M | $5.9M | |||||
| Liabilities | $451.9K | $505.5K | $500.7K | $404.9K | $392.1K | $513.8K | $201.5K | $277.0K | $149.3K | |||||
| Common Stock Value | $712.00 | $712.00 | $712.00 | $189.00 | $120.00 | $109.00 | $1.2K | $1.2K | $1.2K | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -$11.8M | $2.3M | $1.5M | -$229.0K | ||||||||||
| Assets Current | $13.4M | $14.5M | $15.2M | $6.9M | $4.9M | $5.8M | $4.4M | $5.3M | $5.9M | |||||
| Assets | $14.3M | $15.4M | $16.1M | $7.1M | $5.1M | $6.0M | $4.4M | $5.3M | $5.9M | |||||
| Accrued Liabilities Current | $211.4K | $254.2K | $179.1K | $73.2K | $94.4K | $120.6K | $21.6K | $94.5K | $23.7K | |||||
| Accounts Payable Current | $213.5K | $250.7K | $321.7K | $329.3K | $297.7K | $393.2K | $179.9K | $182.4K | $125.6K | |||||
| Prepaid Expense And Other Assets Current | $193.3K | $242.9K | $274.6K | $86.6K | $216.8K | $360.9K | $79.7K | $116.6K | $165.5K | |||||
| Assets Noncurrent | $865.3K | $902.0K | $936.5K | $188.9K | $203.1K | $216.0K | $24.7K | |||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $75.5K | $28.4K | -$57.3K | $13.3K | $3.4K | -$3.6K | $79.6K | $37.8K | $18.2K | |||||
| Property Plant And Equipment Net | $102.0K | $93.8K | $83.4K | $56.4K | $63.1K | $67.7K | $23.9K | |||||||
| Cash And Cash Equivalents At Carrying Value | $2.4M | $3.3M | $1.0M | $765.0K | $1.7M | $2.2M | ||||||||
| Other Short Term Investments | $12.1M | $12.3M | $12.1M | $1.4M | $2.1M | |||||||||
| Equity Securities Fv Ni | $200.0K | $200.0K | $200.0K | $200.0K | $200.0K | |||||||||
| Intangible Assets Net Excluding Goodwill | $763.2K | $147.5K | $55.5K | |||||||||||
| Unrealizedloss Income On Shortterm Investments | -$99.4K | $18.2K | ||||||||||||
| Reclassification Of Deferred Offering Costs To Equity | $202.6K | |||||||||||||
| Contract With Customer Liability Current | $27.0K | $566.00 | $4.00 | $2.4K | ||||||||||
| Accounts Receivable Net Current | $44.9K | $9.4K | $4.9K | $10.00 | ||||||||||
| Cash | $2.4M | $3.3M | $1.0M | $765.0K | $1.7M | $2.2M | ||||||||
| Minority Interest | -$260.9K | -$121.5K | -$46.3K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$3.9M | -$3.3M | -$3.0M | -$1.3M |
| Increase Decrease In Accrued Liabilities | $218.8K | $7.4K | $43.5K | $8.2K |
| Increase Decrease In Accounts Payable | -$68.7K | $122.9K | -$29.9K | $148.8K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $93.9K | $38.5K | $24.7K | $400.00 |
| Payments To Acquire Intangible Assets | $500.0K | $150.0K | $62.8K | |
| Net Cash Provided By Used In Investing Activities | -$9.7M | $67.7K | -$2.5M | -$62.8K |
| Net Cash Provided By Used In Financing Activities | $16.6M | $5.9M | -$75.1K | |
| Share Based Compensation | $136.9K | $119.4K | $936.4K | |
| Payments To Acquire Short Term Investments | $15.7M | $3.5M | $3.5M | |
| Proceeds From Issuance Of Common Stock | $8.2M | $6.0M | ||
| Payments To Develop Software | $83.1K | $45.2K | $57.0K | |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $136.9K | $119.4K | $936.4K | |
| Stock Issued During Period Value Share Based Compensation | $936.4K | |||
| Proceeds From Sale Of Short Term Investments | $6.6M | $4.0M | $1.0M | |
| Increase Decrease In Accounts Receivable | $76.2K | -$8.00 | $8.00 | |
| Payments For Repurchase Of Common Stock | $99.7K | |||
| Proceeds From Warrant Exercises | $2.8M | |||
| Proceeds From Issuance Of Warrants | $2.9M | |||
| Increase Decrease In Contract With Customer Liability | $128.9K | $1.1K | ||
| Stock Issued During Period Value Share Based Compensation Forfeited | $99.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$1.3M | -$1.1M | -$933.9K | -$185.4K | -$3.5K | ||||||
| Increase Decrease In Accrued Liabilities | $117.5K | $66.5K | $13.0K | $10.6K | $2.5K | ||||||
| Increase Decrease In Accounts Payable | -$17.1K | $177.3K | -$119.4K | $119.3K | $6.3K | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $211.0K | $335.8K | $165.1K | $7.4K | |||||||
| Payments To Acquire Intangible Assets | $500.0K | $150.0K | $3.5M | ||||||||
| Net Cash Provided By Used In Investing Activities | -$10.5M | $349.6K | -$3.5M | ||||||||
| Net Cash Provided By Used In Financing Activities | $3.0M | $6.0M | -$43.6K | $2.1M | |||||||
| Share Based Compensation | $32.9K | $15.8K | $870.6K | ||||||||
| Payments To Acquire Short Term Investments | $12.2M | $2.1M | $3.5M | ||||||||
| Proceeds From Issuance Of Common Stock | $159.1K | $6.0M | $2.1M | ||||||||
| Payments To Develop Software | $22.8K | $21.3K | $24.6K | ||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $33.5K | $30.5K | $32.9K | $34.9K | $33.4K | $15.8K | $21.9K | $21.9K | $870.6K | ||
| Stock Issued During Period Value Share Based Compensation | $21.9K | $21.9K | $870.6K | ||||||||
| Proceeds From Sale Of Short Term Investments | $2.2M | $2.6M | |||||||||
| Increase Decrease In Accounts Receivable | $4.9K | $2.00 | |||||||||
| Payments For Repurchase Of Common Stock | $19.6K | ||||||||||
| Proceeds From Warrant Exercises | $417.00 | $104.00 | |||||||||
| Proceeds From Issuance Of Warrants | $2.9M | ||||||||||
| Increase Decrease In Contract With Customer Liability | -$1.1K | ||||||||||
| Stock Issued During Period Value Share Based Compensation Forfeited |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 7.1M | 1.8M | 987.9K | 868.2K | |
| Weighted Average Number Of Diluted Shares Outstanding | 7.1M | 1.8M | 987.9K | 868.2K | |
| Earnings Per Share Diluted | $-0.55 | $-1.92 | $-3.90 | $-1.64 | |
| Earnings Per Share Basic | $-0.55 | $-1.92 | $-3.90 | $-1.64 | |
| Common Stock Shares Issued | 7.1M | 6.9M | 988.4K | 868.2K | 10.4M |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 7.1M | 6.9M | 988.4K | 868.2K | 10.4M |
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 7.1M | 7.1M | 7.0M | 1.4M | 1.1M | 1.0M | 1.0M | 1.0M | 938.4K | 10.4M | 10.4M | 10.4M | 9.0M |
| Weighted Average Number Of Diluted Shares Outstanding | 7.1M | 7.1M | 7.0M | 1.4M | 1.1M | 1.0M | 1.0M | 1.0M | 938.4K | 10.4M | 10.4M | 10.4M | 9.0M |
| Earnings Per Share Diluted | $-0.14 | $-0.11 | $-0.17 | $-0.61 | $-0.72 | $-0.91 | $-0.85 | $-0.75 | $-1.64 | $-0.03 | $-0.04 | $-0.03 | $0.00 |
| Earnings Per Share Basic | $-0.14 | $-0.11 | $-0.17 | $-0.61 | $-0.72 | $-0.91 | $-0.85 | $-0.75 | $-1.64 | $-0.03 | $-0.04 | $-0.03 | $0.00 |
| Common Stock Shares Issued | 7.1M | 7.1M | 7.1M | 1.9M | 1.1M | 12.0M | 12.1M | 12.1M | |||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 7.1M | 7.1M | 7.1M | 1.9M | 1.2M | 1.1M | 12.0M | 12.1M | 12.1M | ||||
| Common Stock Shares Authorized | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | 50.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Additional Paid In Capital | $25.8M | $25.4M | $8.7M | $2.1M | $2.1M |
| Interest And Other Income | $46.5K | $2.9K | |||
| Adjustment For Amortization | $204.7K | $52.4K | $10.6K | $4.2K | |
| Realized Investment Gains Losses | $30.0K | $121.8K | $20.7K | ||
| Investment Income Interest | $612.3K | $157.6K | |||
| Crypto Asset Fair Value Noncurrent | $37.00 | $801.00 | |||
| Stock Issued During Period Value New Issues | $5.8M | ||||
| Stock Issued During Period Value Other | $521.00 | $37.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Additional Paid In Capital | $25.8M | $25.7M | $25.7M | $14.7M | $11.8M | $11.8M | $8.7M | $8.7M | $8.7M | ||||
| Interest And Other Income | $12.0K | $16.6K | $14.6K | $6.3K | $354.00 | $517.00 | $371.00 | ||||||
| Adjustment For Amortization | $29.7K | $8.7K | $3.1K | ||||||||||
| Realized Investment Gains Losses | $10.4K | $2.6K | $11.4K | $2.1K | $119.7K | ||||||||
| Investment Income Interest | $156.0K | $146.9K | $148.2K | $39.4K | $45.3K | $12.0K | $16.6K | $14.6K | |||||
| Crypto Asset Fair Value Noncurrent | $37.00 | $37.00 | $37.00 | $37.00 | $37.00 | ||||||||
| Stock Issued During Period Value New Issues | $159.1K | $5.8M | $960.00 | ||||||||||
| Stock Issued During Period Value Other | $417.00 | $5.8M | $37.5K |
Most recent annual filing with the SEC: March 17, 2026
Data sourced from SEC EDGAR public filings as of August 8, 2026.